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ONTOGENY  OF  B-LYMPHOCYTE  FUNCTION 
III.  In Vivo and In Vitro Studies on the 
Ease of Tolerance Induction  in B  Lymphocytes 
from Fetal,  Neonatal,  and Adult  Mice* 
BY MYRON R.  SZEWCZUK$ AND GREGORY W.  SISKIND 
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Medical College, New York 10021) 
It  has  generally  been  felt  that  tolerance  can  be  induced  more  readily  in 
neonatal than in adult animals.  While this is clearly true in allograft tolerance 
induction (1), it has been less obvious with other antigens. Thus, Siskind et al. 
(2) and Howard and Hale  (3) found no difference between neonatal  and adult 
mice in regard to tolerance induction with polysaccharide antigens and Dresser 
(4)  found that  the  dose of aggregate-free  bovine gamma  globulin  (BGG) 1 re- 
quired to induce tolerance in mice was the same in neonatal and adult animals. 
It has been unclear as to whether immature lymphocytes are or are not more 
sensitive to tolerance induction than  are mature  lymphoid cells.  Recently, in 
vitro  studies  (5-7) have  shown that  tolerance  could be induced  in  vitro  in B 
lymphocytes from immature  donors at antigen  concentrations  far lower than 
that required for tolerance induction in mature B lymphocytes. 
In the studies reported here a  cell transfer system was employed so that the 
susceptibility of B cells to tolerance induction could be assayed in the absence of 
T cells and in a constant, adult, in vivo environment. It was found that with two 
hapten-carrier  conjugates neonatal cells were indeed more susceptible to toler- 
ance induction, both in vivo and in vitro, than were adult B cells. However, with 
BGG as antigen  no difference was detected between B  cells from 17-day fetal 
mice,  neonatal  mice,  and  adult  mice  with  regard  to  the  ease  of tolerance 
induction either in vivo or in vitro.  The results thus suggest that the relative 
ease of tolerance induction in immature  B cells may be limited to moderately 
polyvalent antigens such as hapten-carrier  conjugates. 
Materials  and Methods 
Antigens and Haptens.  BGG (Pentex Fr II) was obtained from Miles Laboratories Inc.  (Elk- 
hart,  Ind.).  The  random  copolymer  of D-glutamic  acid  and  D-lysine  (D-GL;  Miles-Yeda  Ltd., 
* Supported in part by research grant AI-11694  from the U. S. Public Health Service, National 
Institutes of Health. 
$ Recipient of Canada Council, Killam Postdoctoral Research Scholarship S 74-1382 and S 75- 
1465. 
1Abbreviations  used  in  this paper:  BGG,  bovine gamma  globulin;  CFA,  complete Freund's 
adjuvant;  D-GL, copolymer of D-glutamic acid and  D-lysine; DNFB,  1-fluoro-2,4-dinitrobenzene; 
DNP,  2,4-dinitrophenyl;  EACA, E-amino-n-caproic acid;  HBSS,  Hanks'  balanced  salt  solution; 
PFC,  plaque-forming cell; SRBC, sheep erythrocytes; TDsc,~r, dose of antigen for 50% depression 
of immune response. 
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Elkhart,  Ind.) had a  molar ratio of 60:40 and a  mol wt of 34,300.  Dinitrophenylated  D-GL was 
prepared  as  described  by  Katz  et  al.  (8)  and  had  six  hapten  groups  per  molecule.  The  2,4- 
dinitrophenyl  (DNP) derivative of BGG was prepared by the reaction of 1-fluoro-2,4-dinitroben- 
zene (DNFB; Eastman Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.) with BGG 
under alkaline conditions. The procedures for preparations and characterization were described 
previously (9).  DNP22-BGG was used for tolerance induction and the DNP4cBGG was used for 
immunization. DNP-~-amino-n-caproic acid (DNP-EACA) was prepared by the reaction of DNFB 
with EACA (Sigma Chemical Co., St. Louis, Mo.) as described previously (9). 
Animals and Immunization.  LAF1 mice (The Jackson Laboratories, Bar Harbor, Maine) were 
used. Age was designated by taking the day of birth as day 0 and the day of vaginal plug detection 
as day 0 of fetal life. Neonatal liver was obtained within 12 h  of birth. 
Mice were immunized by the intraperitoneal injection of 100 ~g BGG emulsified in complete 
Freund's adjuvant (CFA; containing 1.5 mg/ml Mycobacteria butyricum) so as to be in a final vol of 
0.2 ml. The animals were boosted with a  saline solution of BGG (500/~g) intraperitoneally 3 wk 
later and were sacrificed for plaque-forming cell (PFC) assay 13 days after boosting. Mice were 
immunized with DNP4cBGG by a single intraperitoneal injection of 500/zg in CFA. Splenic anti- 
DNP PFC were assayed 13 days later. 
Cell Transfers.  Studies were carried out as previously described in detail (10,  11), by using 
lethally irradiated (800 R, from a gamma cell 40; Atomic Energy of Canada, Ltd.) thymectomized 
mice reconstituted with syngeneic lymphocytes. The source of fetal or neonatal B lymphocytes was 
the liver and the source of adult B cells was the spleen. Both were treated with anti-brain 0 and 
complement.  B cells from several donors were pooled. Recipients received the equivalent of the 
cells from one adult spleen (approximately l0  s nucleated cells) or from one fetal or neonatal liver 
(approximately 3 ×  107 nucleated cells) 2-4 h after irradiation. The tolerance inducing injection of 
antigen was given 1 day after cell transfer. 3-13 days later all animals received 1 ×  l0  s syngeneic 
adult thymus cells, pooled from several adult donors. The anti-brain 0 antiserum was prepared by 
immunizing rabbits with CBA/J mouse brain in CFA as described and characterized previously 
(11). 
Assay of Number and Avidity of PFC.  Anti-BGG PFC in the spleen were determined by the 
method ofJerne et al. (12) as modified for slide assay by Dresser and Greaves (13). The slides were 
incubated for i h at 37°C. Freshly frozen guinea pig serum, absorbed with 50% sheep erythrocytes 
(SRBC) was added, at a 1/30 dilution, as a source of complement and the slides were incubated for 
an additional  21/2 h.  Rabbit anti-mouse  gamma globulin was used at  1:200 dilution to develop 
indirect plaques. The target cells to detect anti-BGG PFC were prepared as described by Golub et 
al. (14) by coupling 24 mg BGG to 0.5 ml washed, packed SRBC in phosphate-buffered saline, pH 
6.0, by using 250 mg 1-ethyl-3 (3-dimethylaminopropyl)-carbodiimide HC1 (Sigma Chemical Co.). 
Anti-DNP PFC were detected by use of picryl coated SRBC as described previously (10, 11, 15). 
The avidity distribution  of the PFC was assayed by inhibition of plaque formation by using 
various concentrations of ligand essentially according to the method of Andersson (16) as validated 
previously (17, 18). Plaque formation around high affinity antibody secreting cells is inhibited by a 
low concentration of hapten while plaque formation about low affinity antibody secreting cells is 
only inhibited by high concentrations of hapten. Concentrations of BGG ranging from 1 × 10  -~1 to 
1 x  10 -7 M and concentrations of DNP-EACA ranging from I  ×  10 -9 to I  × 10 -5 M, both in half-log 
increments, were used. 
In  Vivo  Induction  of Tolerance.  Tolerance  to  BGG  was  induced  by  a  single  intravenous 
injection of between 1 and 250/zg ultracentrifuged (133,575 g  at middle for 150 rain in a Beckman 
50 Ti rotor, Beckman Instruments, Inc., Fullerton, Calif.) antigen dissolved in saline (30 mg/ml) 
essentially as described by Dresser (4). BGG concentration was determined from its absorbancy at 
•  lO/c  280 nm. E1 c,,  =  12.1 (19). 13 days later, all animals received I  ×  109 syngeneic adult thymus cells 
and thereafter were challenged with BGG in CFA. DNP-specific B-cell tolerance was induced in 
reconstituted  irradiated mice by the intravenous injection of 5 t~g of either DNP6-D-GL (20) or 
ultraeentrffuged  DNP2~-BGG.  3-6  days  later  all animals  were  given 1  ×  10  s  syngeneie  adult 
thymus cells and 1 day later were challenged with DNP~-BGG in CFA. 
In  Vitro  Induction of Tolerance.  Tolerance was  induced  in  vitro as  described  by previous 
workers  (6).  Spleen cells from adult  mice  (6-8 wk old) or liver cells from neonatal  mice were 
treated with anti-brain 0 antiserum and complement. The cells were washed twice with sterile 
media consisting of Hanks' balanced salt solution (HBSS), 5  ×  10 -5 M 2-mercaptoethanol,  100 U 
penicillin/ml and 100 ~g streptomycin/ml, and 5% fetal calf serum. The cells were cultured, for 24 1592  ONTOGENY  OF  TOLERANCE  SUSCEPTIBILITY  OF  B  CELLS 
h at 37°C, under a 5% CO2/balance air atmosphere, in 60-mm plastic Petri dishes containing 4 ml of 
sterile medium at a cell density of 1 x  107 nucleated cells/ml. Cells were cultured with or without 
0.1/zg/ml ultracentrifuged BGG, DNPs-D-GL, or DNP22-BGG. After incubation for 24 h  the cells 
were scraped off the Petri dishes; the telerogen was removed by washing three times with cold 
HBSS; and the cells were injected intravenously into lethally irradiated syngeneic mice.  Each 
recipient was given 2-3  x  107 cultured cells plus 1  ×  l0  s normal thymus cells.  1 day after cell 
transfer all animals were challenged with BGG or DNP44-BGG in CFA. 
Results 
Comparison  of B Lymphocytes  from Fetal,  Neonatal, and Adult Mice with 
Regard to Ease of Tolerance Induction In Vivo with Deaggregated BGG.  The 
ease of tolerance induction of B lymphocytes from adult, neonatal, and fetal 
mice was assayed by determining the dose-response curve for tolerance induc- 
tion with deaggregated BGG.  Lethally irradiated, thymectomized mice were 
reconstituted with B cells from neonatal or fetal liver, or adult spleen or bone 
marrow. 1 day later they were injected with tolerogen. All animals received 1 x 
108 thymus cells 13 days thereafter and were challenged with BGG in CFA 1 day 
later. The dose-response curves for B-cell tolerance induction in mice reconsti- 
tuted with B  lymphocytes from adult spleen,  adult bone marrow, 8-day-old 
spleen, neonatal liver, and 17-day fetal liver were strikingly similar (Fig. 1). In 
each case the degree of unresponsiveness increased with increasing doses of 
deaggregated BGG: approximately 50% depression being obtained with 3 fig of 
tolerogen except in mice reconstituted with B lymphocytes from 14-day fetal 
donors which were relatively resistant to tolerance induction.  In each case, 
except day  14  fetal  liver,  doses  of tolerogen between 8  and  20  ~g  caused 
approximately a  60%  depression in  the  immune response.  Higher doses  of 
tolerogen were only employed in recipients of 14-day fetal liver, neonatal liver, 
and  adult  spleen.  Mice  reconstituted with  neonatal  liver  and  adult  spleen 
behaved indistinguishably: approximately 85% depression in the anti-BGG re- 
sponse being obtained after 100/zg of tolerogen. In contrast, a  dose of 100/zg 
deaggregated BGG brought about only a  39% depression in the immune re- 
sponse of mice reconstituted with day 14 fetal liver. 
From the dose-response curves one can estimate the dose of antigen (TDso~o) 
required to bring about a 50% depression in splenic anti-BGG PFC. The value 
for the TDso~o offers a convenient parameter by which to compare the relative 
ease of  tolerance induction in different  B-cell populations (Fig. 2). It is clear that 
the ease of tolerance induction in B lymphecytes, with deaggregated BGG,  is 
essentially identical in all groups except those animals reconstituted with 14- 
day fetal liver which were highly resistant to tolerance induction. 
Effect of  Partial Tolerance on the Avidity of the Anti-BGG PFC.  The effect of 
partial tolerance (induced with the TDso~o dose of deaggregated BGG: 3 ftg) on 
the distribution of avidities of PFC was studied in mice reconstituted with either 
anti-brain 0 antiserum-treated adult spleen or neonate liver as the source of B 
lymphocytes (Fig. 3, Table I). A highly heterogenous response was obtained in 
control mice reconstituted with  adult  spleen cells.  In contrast,  as  we have 
previously reported (10, 15), the control mice reconstituted with neonatal liver 
as  the  source  of B  lymphocytes produced a  response  which was  relatively 
restricted in heterogeneity. In both cases, partial tolerance resulted in a statisti- 
cally significant decrease in heterogeneity  and in avidity. These findings, taken MYRON  R.  SZEWCZUK  AND  GREGORY  W.  SISKIND 
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Dose-response curves for  tolerance induction with deaggregated BGG. Irradiated 
together with the fact that tolerance was induced in the absence of T lympho- 
cytes, suggest a B-cell clonal deletion type mechanism for this tolerant state. 
In  Vivo  Induction  of  B-Lymphocyte  Tolerance  with  Polyvalent  Anti- 
gens.  Recent  in  vitro  studies  with  polyvalent  hapten-carrier  conjugates  as 
tolerogens have indicated that  B  lymphocytes from neonatal  donors are more 
easily rendered  tolerant  than  are  B  cells  from  adult  animals  (6,  7).  It  was 
FIG.  1. 
thymectomized mice were reconstituted with anti-brain 0 antiserum-treated spleen, bone 
marrow, or fetal or neonatal liver as the source of B lymphocytes.  1 day after cell transfer 
groups of animals received doses of deaggregated BGG, intravenously, ranging from 1 to 250 
I~g.  Control  animals,  which did not receive tolerogen,  were  included.  13  days  later all 
animals received I  ×  108 syngeneic thymus cells, intravenously, and were immunized 24 h 
thereafter with 100/~g BGG in CFA, intraperiteneally. 3 wk later all animals were boosted 
with 500 ~g BGG, intraperitoneally, and their splenic anti-BGG indirect PFC were assayed 
13 days after boosting. The abscissa represents the dose of deaggregated BGG. The ordinate 
represents  the  percent  depression  of the  number of splenic  anti-BGG indirect  PFC  in 
tolerant animals  as  compared with the appropriate  controls.  Each point represents the 
percent depression of the arithmetic mean of the number of PFC,  relative to controls, in 
groups of three to five mice. The results illustrated are  in each case one representative 
example out of 2-13 independent dose-response curves obtained on mice reconstituted with 
each of  the indicated sources of  B lymphocytes. 1594  ONTOGENY  OF  TOLERANCE  SUSCEPTIBILITY  OF  B  CELLS 
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Fro.  2.  Ontogeny of the ease of tolerance induction in mouse B lymphocytes with deaggre- 
gated BGG. The dose of deaggregated BGG required for a 50% depression of the indirect 
PFC response (TDs0.~), relative to appropriate controls, were obtained from dose-response 
curves such as those illustrated in Fig. 1. Along the abscissa is indicated the source of B 
lymphocytes used  to  reconstitute  the  lethally  irradiated  thymectomized mice  and  the 
ordinate  represents  the  TDs~.  The  average value  for TDso~o calculated  from  2  to  13 
independent dose-response  curves is presented. The number in parentheses associated with 
each point indicates the number of dose-response  curves obtained. 
therefore  deemed  important  to  study  the  ease  of tolerance  induction  in  B 
lymphocytes, in vivo, by using such antigens.  Tolerance induction with DNP~- 
D-GL  and  ultracentrifuged  DNP22-BGG was  studied  in  irradiated  thymecto- 
mized mice reconstituted with B cells from neonatal or adult donors. It should be 
noted that tolerance induction took place in the absence of T lymphocytes. The 
data, presented in Table II, are consistent with the conclusion that B cells from 
neonatal mice are more readily rendered tolerant to these antigens than are B 
cells from adult donors. 
In  Vitro  Induction  of B-Lymphocyte  Tolerance.  Anti-brain  0  antiserum- 
treated adult spleen or neonatal liver cells were maintained in culture for 24 h in 
the presence or absence of 0.1/~g/ml tolerogen (DNP6-D-GL, deaggregated BGG, 
or DNP~-BGG). The cells were then washed, mixed with normal thymus cells, 
and injected intravenously into lethally irradiated syngeneic mice. Each recipi- 
ent received 3  ×  107 cultured cells plus 1 ×  l0  s normal adult thymus cells and 
was immunized  with DNP44-BGG or BGG in CFA 1 day later.  There was no 
difference between B cells from neonatal and adult mice with regard to the ease 
of tolerance induction with ultracentrifuged  BGG in vitro  (Table HI). In con- 
trast, B cells from neonatal mice were markedly more susceptible than B cells 
from adult donors to in vitro tolerance induction with DNP22-BGG or DNPe-D- 
GL (Table HI). 
Discussion 
The susceptibility to tolerance  induction  of B  lymphocytes from fetal,  neo- 
natal,  and adult mice was studied in vitro and in vivo in a cell transfer system. MYRON  R.  SZEWCZUK  AND  GREGORY  W.  SISKIND  1595 
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Fro.  3.  Effect  of partial tolerance  on  antibody  avidity.  Each  histogram  illustrates  the 
distribution of anti-BGG indirect PFC with respect to avidity in the spleen of an individual 
mouse. The abscissa represents the log of the inverse of the free hapten concentration used 
in the plaque inhibition assay. The ordinate represents the percent of the total population of 
PFC  present  in  each  subpopulation.  The  animal  identification  number  (top)  and  total 
indirect PFC per spleen  are given  in  the upper right corner  of each histogram.  Avidity 
increases to the right.  Tolerant  mice had received  a  tolerance  inducing injection of 3  ~g 
deaggregated  BGG  intravenously.  Controls  were  injected  with  saline.  2  wk  after  the 
injection of tolerogen all animals were immunized with 100/~g BGG in CFA intraperitone- 
ally  and  were  boosted  with 500  t~g  BGG,  intraperitoneally,  3  wk later.  The  anti-BGG 
indirect PFC in the spleen were assayed 13 days after boosting. The top two rows illustrate 
data on tolerance induction in irradiated thymectomized mice reconstituted with anti-brain 
0  antiserum  treated adult spleen cells.  The bottom two rows illustrate data on tolerance 
induction  in  irradiated  thymectemized  mice  reconstituted  with  anti-brain  0  antiserum 
treated neonatal liver cells.  The tolerance  inducing injection of antigen was given  1 day 
after reconstitution with B  cells and all animals received  1  x  l0  s adult syngeneic thymus 
cells 1 day before challenge with BGG in CFA. 1596  ONTOGENY  OF  TOLERANCE  SUSCEPTIBILITY  OF  B  CELLS 
TABLE  I 
Effect of Partial Tolerance to BGG on Antibody Avidity and Heterogeneity* 
Depression of  Experimental  Treatment  Avidity*  Heterogeneity§ 
animals reconsti-  PFC in toler- 
(no. of mice)  K~o~  ×  10  -6  index 
tuted with  ant mice 
Adult spleen~ 
% 
Control  (10)  6.1  2.57  +_ 0.25 
41 
Tolerant (10)  0.9  1.57  +_ 0.62 
P  <  0.002 
Neonatal liver0  Control  (14)  0.8  1.47  _+ 0.46 
55 
Tolerant (9)  0.1  1.01  _+ 0.30 
P  <  0.02 
* Lethally irradiated thymectemized mice were reconstituted as indicated in the first column. 
Animals received anti-brain 8-treated adult spleen cells or anti-brain 0-treated neonatal liver 
cells.  1 day after cell transfer half of the mice received a  tolerance inducing injection of 3  ~zg 
deaggregated BGG intravenously while the remaining mice were used as controls. 13 days later 
all animals received 1  x  10  s syngeneic thymus cells intravenously and 1 day thereafter were 
immunized with 100 ftg BGG in CFA intraperitoneally. 21 days later all animals were boosted 
with 500  pg BGG intraperitoneally and their splenic anti-BGG indirect PFC were assayed 13 
days after boosting. The avidity distributions of some of these animals are illustrated in Fig. 3. 
The depression in number of PFC was found to be significant (P <  0.002) by the Mann-Whitney 
U test. A t test was used to evaluate significance of differences in the heterogeneity indices. 
$ Geometric mean of the reciprocal of the concentration of hapten required for 50% inhibition of 
the number of indirect PFC. 
§ The Shannon heterogeneity index (29) was used to describe the degree of heterogeneity of avidity 
of the anti-BGG indirect PFC population of individual animals. The average value +- standard 
deviation, of this index for each of the experimental groups is presented. The larger the index the 
greater the heterogeneity. 
TABLE  II 
In Vivo Induction of Tolerance in Neonatal or Adult Mouse B Lymphocyte Populations 
with DNPe-D-GL and Deaggregated DNP-BGG* 
Experimental animals 
Toleregen 
Exp.  DNP~-D-GL  DNP2~-BGG 
no. 
Reconstituted 
Treatment  Anti-DNP PFC  Depression  Anti-DNP PFC  Depression 
with 
%  % 
1  Adult spleene  Control  2,460 (2)  29  2,000 (3)  0 
Toleregen  1,740 (2)  2,850 (2) 
Neonatal livere  Control  7,920 (2)  89  1,245 (2)  78 
Toleregen  908 (4)  270 (3) 
2  Adult spleen,  Control  6,380 (5)  9  6,380 (5)  18 
Tolerogen  5,790 (3)  5,220 (4} 
Neonatal livere  Control  5,740 (6)  75  5,740 (6)  78 
Toleregen  1,460 (5)  1,270 (6) 
* Lethally irradiated thymectomized mice were reconstituted as indicated in the second column. Animals received 3-5 x  10  ~  anti- 
brain 8 antiserum-treated neonatal liver cells or 7-10  ×  107 anti-brain 0 antiserum-treated adult spleen cells.  1 day after cell 
transfer half of the animals were injected intravenously with 5 ~g of toleregen (DNPs-D-GL  or deaggregated DNP22-BGG). 
Controls were not injected with toleregen. 3 days after DNP~-D-GL or 6 days atter DNP~-BGG injection all animals received 1 x 
108 syngeneic thymus cells, intravenously, and 1 day thereafter were immunized with 500 ~tg DNP~-BGG in CFA. Splenic anti- 
DNP PFC were assayed 13 days after immunization. The results are presented as the average number of indirect PFC per spleen. 
The number of animals studied is indicated in parentheses. Two representative experiments with each teleregen are presented. MYRON  R.  SZEWCZUK  AND  GREGORY  W.  SISKIND  1597 
TABLE  IH 
In Vitro Induction of Tolerance in Neonatal or Adult Mouse B-Lymphocyte Populations with 
Deaggregated  BGG, DNP6-D-GL, and DNPzz-BGG* 
Tolerogen 
Exp.  Cultured  cells  In vitro  treat-  BGG  DNP6-D-GL  DNP~2-BGG 
no.  ment 
Anti-BGG PFC  Anti-DNP PFC  Anti-DNP PFC 
(No. of mice)  Depression  (No. of mice)  Depression  (No. of mice)  Depression 
%  %  % 
1  Adult spleens  Control  62,530  (2)  75  31,550 (2)  48  5,330  (4)  39 
Toleregen  15,830 (4)  16,240 (2)  3,660  (4) 
Neonatal  liver  s  Control  59,600 (2)  74  2,660  (3)  77  2,440  (4)  74 
Tolerogen  15,820 (5)  617 (3)  640 (3) 
2  Adult spleens  Control  94,350  (2)  36  5,600  (5)  0  5,600  (5)  29 
Tolerogen  60,150  (3)  6,450  (2)  3,950  (3) 
Neonatal  livero  Control  60,740  (3)  20  3,180  (5)  85  3,180  (5)  81 
Tolerogen  48,520  (3)  480 (2)  620 (2) 
* Anti-hrain 0 antiserum-treated  adult spleen cells  or anti-brain 0 antiserum-treated  neonatal liver  cells  were maintained in tissue  culture 
at a cell  density of  i × 107 cens/ml  for 24 h with or without 0.1 ~g/ml tolerogan. The cells  were then harvested and were washed three 
times. 3 × 107 nucleated cells  from each group were mixed with 1 x I0' syngeneic thymus cells  and were injected intravenously  into 
lethally irradiated syngeneic  mice. Recipients were immunized  1 day later  with either DNP~-BGG  or BGG. Splenic anti-DNP or anti- 
BGG  PFC were assyed 13 days aRer immunization or boosting, respectively. The results are expressed as the geometric  mean of the 
number of indirect PFC per spleen. The number of animals studied is indicated in parenthesis. Two independent experiments  are 
presented with each telerogen. In exp, 2, DNPe-D-GL  and DNP~z-BGG  tolerance induction was done simultaneously  by using a single 
group of  controls. 
It was found that with ultracentrifuged BGG,  B cells from 17-day fetal, neo- 
natal, 8-day old and adult mice were equivalent with respect to ease of tolerance 
induction in vivo. In addition, B cells from adult spleen and bone marrow were 
equally susceptible to tolerance induction, in vivo, with deaggregated BGG. 
Similarly, in vitro, B cells from neonatal and adult donors were equally suscep- 
tible to tolerance induction with deaggregated BGG. In marked contrast, B cells 
from neonatal donors were more readily tolerized with DNPe-D-GL or ultracen- 
trifuged DNP22-BGG than were B cells from adult mice both in vivo and in vitro. 
It should be noted that tolerance was induced in the absence of T cells. 
The partial tolerant state induced with deaggregated BGG in lethally irradi- 
ated,  thymectomized mice reconstituted with neonatal or adult B  cells was 
shown to be characterized by a marked depression in the avidity of the residual 
PFC. Furthermore, the tolerance was induced in T-cell depleted mice. Thus, it 
appears reasonable to regard this tolerant state as being mediated by a B-cell 
clonal deletion type mechanism. In previous studies  (11) we established,  by 
extensive cell transfer experiments, that the tolerant state induced in reconsti- 
tuted irradiated adult mice with DNP-BGG is definitely due to a B-cell clonal 
deletion type mechanism. DNP-D-GL has been studied in detail and is known to 
be  a  B-cell  tolerogen  (20). Thus,  it  would appear  likely that the models of 
tolerance studied here all represent B-cell clonal deletion type mechanisms and 
are therefore appropriate models to study the direct susceptibility of different B- 
lymphocyte populations to tolerance induction. 
B cells from neonatal mice have been reported by previous workers to be far 
more susceptible to tolerance induction in vitro with hapten-carrier conjugates 
than are B cells from adult animals (6,  7).  Immature B cells from the bone 1598  ONTOGENY  OF  TOLERANCE  SUSCEPTIBILITY  OF  B  CELLS 
marrow were also found to be more readily tolerized than mature peripheral B 
cells (5). In addition, immature B cells are more susceptible than mature B cells 
to suppression by anti-idiotype antibodies (21). Furthermore, immature B cells 
have been shown to require a  higher concentration of anti-immunoglobulin 
antibody to  bring  about  capping  of surface immunoglobulin, and to  fail  to 
resynthesize surface immunoglobulin after capping as do mature B lymphocytes 
(22, 23). These observations have led workers to conclude that a high degree of 
sensitivity to tolerance induction is a basic property of immature B lymphocytes, 
and to assume that this property is critical for the normal establishment of self 
tolerance. There have been numerous observations which suggest that tolerance 
can be more readily induced in neonatal than in adult animals. On the other 
hand, studies with T-independent  polysaccharide  antigens have failed to demon- 
strate a similar enhanced susceptibility to tolerance induction in vivo during the 
neonatal period (2, 3). Furthermore, Dresser (4) found no difference in the dose 
of deaggregated BGG required to tolerize neonatal and adult mice. To some 
extent the studies reported here help to clarify these apparent discrepancies. It 
was found that with polyvalent hapten-carrier conjugates there is  indeed a 
greater ease of tolerance induction in B  cells from immature animals.  This 
increased ease of tolerance induction was demonstrated both in vivo and in 
vitro. In contrast, with deaggregated BGG no difference in ease of tolerance 
induction was demonstrable either in vivo or in vitro when comparing B cells 
from  immature and  adult  donors.  Thus,  a  high  susceptibility to  tolerance 
induction cannot be regarded as a general property of immature B cells with 
respect to all antigens. 
Immature B cells, after capping and shedding of surface immunoglobulin, fail 
to resynthesize surface immunoglobulin on further culture while mature B cells 
rapidly resynthesize surface immunoglobulin (22, 23). The failure to resynthe- 
size surface immunoglobulin antigen receptors could result in a clonal deletion 
type tolerance after their capping  and  shedding as  a  consequence of cross- 
linking with  a  polyvalent antigen.  It  is  with polyvalent antigens  (hapten- 
protein conjugates) that we and previous workers (5-7) have detected a differ- 
ence between immature and mature B cells in regard to the ease of tolerance 
induction.  With  an antigen,  such as BGG,  which does not contain multiple 
identical determinants, B-cell tolerance induction might involve other mecha- 
nisms than cross-linking of receptors, and with these mechanisms there is no 
difference between mature  and  immature B  cells.  Polysaccharide antigens 
clearly consist of multiple repeating determinants but immature B cells do not 
appear to differ from adult B cells with regard to susceptibility to tolerance 
induction  (2,  3).  It  is  possible  that  with  these  highly polyvalent  antigens 
tolerance induction is through the formation of a  stable cross-linked matrix 
(24) which takes  place  with  equal  facility in  mature  and  immature B-cell 
populations. It should be noted that both BGG and DNP-BGG are T-dependent 
antigens  (11  and unpublished observations).  Therefore, T  dependence of the 
antigen does not appear to be the critical factor in determining whether imma- 
ture B cells will be more susceptible to tolerance induction with that antigen. 
It is probable that several different processes can lead to an unresponsive B- 
cell population. Immature B cells appear to be more suceptible than mature B 
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brings up the question of self tolerance. The clonal abortion theory (25) which 
emphasizes a tolerance susceptible phase during the development of B cells is 
very attractive as a model for self tolerance. However, the polyvalent hapten- 
carrier conjugates, with which the relative ease of tolerance induction in imma- 
ture B cells can be demonstrated, probably represent poor models of the usual 
self antigen. It seems possible that BGG represents a better model for a  self 
antigen. Since in tolerance induction with BGG no difference between mature 
and immature B cells is observed, one must seriously question the extent to 
which a difference in the ease of tolerance induction in immature and mature B 
cells plays an important role in controlling self tolerance induction. However, 
the possibility must also be considered that BGG actually represents an unusual 
example reflecting some special handling of immunoglobulins. 
Finally a note should be made of the interesting finding that mice reconsti- 
tuted  with  B  cells  from  14-day  fetal  donors  were  particularly resistant  to 
tolerance induction. The precise mechanism is unclear. It is possible that this 
relative resistance to tolerance induction reflects the fact that B-cell  surface 
antigen receptors are not yet fully expressed in the 14-day fetus (26). In addition, 
evidence has been reported which suggests that IgG precursor cells are more 
sensitive to tolerance induction than are IgM precursors (27, 28). It has been 
previously shown that cells from 14- or 16-day fetal mice produce mainly IgM 
PFC.  Between day 16  and  17  of fetal life the capacity of B  cells to produce 
indirect PFC develops (10, 15). It is also possible  that rapid proliferation of this 
immature B-cell population is  at least in part responsible for the failure to 
induce tolerance. If the cell population is rapidly proliferating, competent cells 
may quickly arise after clearance of  the tolerogen and an unresponsive state will 
not be observed. In any event it is clear that even relatively early fetal B-cell 
populations are not particularly susceptible to tolerance induction with deaggre- 
gated BGG. 
Summary 
The ease of tolerance induction in B lymphocytes from fetal, neonatal, and 
adult mice was studied in vivo,  in a  cell transfer system, and in vitro. Three 
different tolerogens were used: ultracentrifuged BGG,  DNP6-D-GL, and ultra- 
centrifuged DNP22-BGG. Irradiated thymectomized mice were reconstituted 
with B cells from fetal or neonatal liver or adult spleen or bone marrow. The 
mice were injected with tolerogen 1 day later. They were given normal thymus 
cells and challenged with either BGG or DNP44-BGG between 4 and 14 days 
after tolerance induction. With BGG no difference in ease of B-cell  tolerance 
induction was observed in mice reconstituted with B cells from 17-day fetal liver, 
neonatal liver, 8-day-old spleen,  adult spleen, or adult bone marrow. B cells 
from  14-day  fetal  donors  are  relatively resistant  to  tolerance induction.  In 
contrast, with DNP6-D-GL and DNP22-BGG B cells from neonatal donors were 
clearly more susceptible to tolerance induction than were B cells from adult 
donors. Comparable results were obtained in studies on tolerance induction in 
vitro. Neonatal B cells were more susceptible than adult B cells to tolerance 
induction upon culture with DNP6-D-GL or DNP22-BGG. However, neonatal and 
adult B cells were identical with respect to ease of tolerance induction in vitro 
with deaggregated BGG. 1600  ONTOGENY  OF  TOLERANCE  SUSCEPTIBILITY  OF  B  CELLS 
The results suggest that there are multiple mechanisms for B-cell tolerance 
induction. Immature B cells appear to be more susceptible to tolerance induction 
by some mechanisms but not by others. It is suggested that immature B cells are 
more susceptible to tolerance induction with moderately polyvalent antigens 
such as hapten-carrier conjugates. With antigens like BGG which do not have 
repeated epitopes no difference between mature and fetal B  cells in regard to 
ease of  tolerance induction is observed. These observations raise questions about 
the importance of relative ease of tolerance induction in immature B cells as a 
mechanism controlling the normal induction of self tolerance. 
Received for publication  28 January 1977. 
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